← Back to headlines
Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial - WSJ
Roche Multiple Sclerosis Drug Meets Main Goal in Late-Stage Trial WSJ
2 Mar, 16:31 — 2 Mar, 16:31
Sources
Showing 1 of 1 sources
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
1h ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
3h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
3h ago
Study Reveals Hidden Arterial Calcification in Young Adults
5h ago